Medical device recalls Moderate risk

Siemens Healthcare Diagnostics, Inc recalls ADVIA Centaur PSA Assay; Catalog Number: 06574155/SMN 10310292 (100 test kit) and Catalog Number: 02676506/SMN 10310293…

Recall date
December 29, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0754-2016
FDA classification
Class II
Brand / firm
Siemens Healthcare Diagnostics, Inc
Sold / distributed
Worldwide - US Nationwide including Puerto Rico, OUS: Albania, Algeria, Angola, Armenia, Austria, Bahrain, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Great Britain, Greece, Hungary, Iceland, Iraq, Italy, Jordan, Kazakhsta…

Why it was recalled

PSA assay is not meeting the High Dose Hook Effect expectation in the Instructions for Use (IFU).

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

ADVIA Centaur PSA Assay; Catalog Number: 06574155/SMN 10310292 (100 test kit) and Catalog Number: 02676506/SMN 10310293 (500 test kit) Product Usage: This in vitro diagnostic assay is intended to quantitatively measure prostate-specific Antigen (PSA) in human serum using the ADVIA Centaur/XP/XPT/CP Systems.

Get recall alerts

Free email alert whenever Siemens Healthcare Diagnostics, Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Siemens Healthcare Diagnostics, Inc